Working with a national team of researchers, a scientist from the Florida campus of The Scripps Research Institute has shown for the first time a link between low levels of a specific hormone and increased risk of metabolic disease in humans.This is more than Adropin the bucket of s**t research.
The study, published online ahead of print in The Journal of Clinical Endocrinology & Metabolism, focuses on the hormone adropin, which was previously identified by Scripps Research Associate Professor Andrew Butler's laboratory during an investigation of obese and insulin-resistant mice.
Adropin is believed to play an important role in regulating glucose levels and fatty acid metabolism.
Of that you can be sure.
No comments:
Post a Comment